(Q53675674)

17 May 2018

title

ATTEMPTS: a heparin/protamine-based delivery system for enzyme drugs. (English)

1 reference

17 May 2018

author name string

Liang JF

1

1 reference

17 May 2018

Li YT

2

1 reference

17 May 2018

Song H

3

1 reference

17 May 2018

Park YJ

4

1 reference

17 May 2018

Naik SS

5

1 reference

17 May 2018

Yang VC

6

1 reference

17 May 2018

language of work or name

English

0 references

publication date

1 January 2002

1 reference

17 May 2018

Journal of Controlled Release

published in

1 reference

17 May 2018

volume

78

1 reference

17 May 2018

issue

1-3

1 reference

17 May 2018

page(s)

67-79

1 reference

17 May 2018

Comparative effects of tissue plasminogen activator, streptokinase, and staphylokinase on cerebral ischemic infarction and pulmonary clot lysis in hamster models

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900484-9

7 January 2021

Antibody-directed enzyme prodrug therapy (ADEPT): a review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900484-9

7 January 2021

Antibody directed enzyme prodrug therapy (ADEPT). A review of some theoretical, experimental and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900484-9

7 January 2021

Antibody-directed enzyme prodrug therapy (ADEPT). A three-phase study in ovarian tumor xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900484-9

7 January 2021

Delivery system for targeted thrombolysis without the risk of hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900484-9

7 January 2021

A recombinant prodrug type approach for triggered delivery of streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900484-9

7 January 2021

An investigation of heparinase immobilization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900484-9

7 January 2021

Low molecular weight protamine: a potential nontoxic heparin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900484-9

7 January 2021

Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900484-9

7 January 2021

The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900484-9

7 January 2021

Molecular modeling of protein-glycosaminoglycan interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900484-9

7 January 2021

10.1016/S0168-3659(01)00484-9

Identifiers

DOI

1 reference

17 May 2018

release_cmvo63emlnfebeqdeuiheffssa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cmvo63emlnfebeqdeuiheffssa

24 November 2022

mapped directly with Wikidata item

1 reference

17 May 2018